A novel, simple, and rapid flow-injection method for the spectrophotometric determination of captopril in pharmaceutical products, using a solid-phase reactor with silver chloranilate (Ag 2 C 6 Cl 2 O 4 ) immobilized in a polyester resin, is presented. This method explored the formation of an insoluble salt between Ag(I) and captopril in the solid-phase reactor, releasing chloranilate anion (C 6 Cl 2 O 2À 4 ). Then, this anion reacted with ferric ions to produce a complex, FeC 6 Cl 2 O þ 4 , which was monitored spectrophotometrically at 528 nm. The analytical curve was linear in the captopril concentration range from 1.0 Â 10 À5 to 5.0 Â 10 À4 mol l À1 with a detection limit of 8.0 Â 10 À6 mol l À1 . The relative standard deviation (RSD) was 0.35% (n ¼ 10) for a solution of 3.0 Â 10 À4 mol l À1 captopril solution, and an analytical frequency of 70 h À1 was obtained. The effects of excipients frequently found with captopril in pharmaceutical formulations, such as lactose, microcrystalline cellulose, starch, and magnesium stearate, were evaluated using the proposed flow-injection method. None of these substances caused significative interference 973 in the proposed method. The method was successfully applied to the determination of captopril in pharmaceutical products, and the results were compared with results obtained using a potentiometric method.